第69回日本アレルギー学会学術大会

セッション情報

印刷

Poster Session

Internal Medicine

[PE1] Poster Session 1
Adult airway diseases

[PE1-3] Exacerbation clusters demonstrate asthma and Chronic Obstructive Pulmonary Disease (COPD) overlap with distinct phenotypes

Kentaro Hyodo1,3, Hironori Masuko1, Hisayuki Oshima1, Rie Shigemasa1, Haruna Kitazawa1, Jun Kanazawa3, Hiroaki Iijima2, Takahide Kodama4, Akihiro Nomura5, Katsunori Kagohashi1, Hiroaki Sato1, Takefumi Saito3, Tohru Sakamoto1, Nobuyuki Hizawa1 (1.Department of Pulmonary Medicine (Majors of Medical Sciences, Graduate School of Comprehensive Human Sciences), University of Tsukuba, Japan, 2.Tsukuba Medical Center, Japan, 3.National Hospital Organization Ibarakihigashi National Hospital, Japan, 4.Ryugasaki Saiseikai Hospital, Japan, 5.Ibaraki Seinan Medical Center Hospital, Japan)

[PE1-4] Anti-allergy medication utilization in patients with chronic cough

Xiao Luo1, Wei Shao5, Zuoyi Zhang5, Zhi Han2,5, Vasu Chandrasekaran3, Vladimir Turzhitsky3, Vishal Bali3, Keisuke Tobe3, Machiko Abe3, Anna Roberts2, Megan Metzger2, Jarod Baker2, Carmen La Rosa3, Jessica Weaver3, Paul Dexter2,4,5, Kun Huang2,5 (1.School of Engineering and Technology, Purdue University, USA, 2.Regenstrief Institute, Inc., USA, 3.Center for Observational and Real-World Evidence, Merck & Co., Inc., USA, 4.Eskenazi Health, USA, 5.School of Medicine, Indiana University, USA)

[PE1-5] Burden of persistent chronic cough in adults in a large managed care organization

Deshaun Parris1, Robert Zeiger1, Michael Schatz1, Benjamin Hong2, Fagan Xie2, Vishal Bali1, Jessica Weaver1, Jonathan Schelfhout1, Wansu Chen2, Keisuke Tobe1 (1.Center for Observational and Real-World Evidence (CORE), Merck & Co. Inc., USA, 2.Departments of Allergy and Research and Evaluation, Kaiser Permanente Southern California (KPSC), USA)

[PE1-7] Baseline characteristics from phase 3, randomized controlled trials (COUGH-1 and COUGH-2) of gefapixant, a P2X3 receptor antagonist, in refractory or unexplained chronic cough

David Muccino1, Masashi Kikuchi2, Alyn H Morice3, Surinder S Birring4, Lorcan McGarvey5, Peter V Dicpinigaitis6, Ian D Pavord7, Carmen La Rosa1, Christopher Assaid1, Jaclyn A Smith8 (1.Merck & Co., Inc., USA, 2.MSD K.K., Japan, 3.Hull York Medical School, UK, 4.Division of Asthma, Allergy and Lung Biology, King's College London, UK, 5.Centre for Experimental Medicine, Queen's University Belfast, UK, 6.Albert Einstein College of Medicine and Montefiore Medical Center, UK, 7.Oxford NIHR Respiratory BRC, Nuffield Department of Medicine, University of Oxford, UK, 8.Division of Infection, Immunity and Respiratory Medicine, University of Manchester, UK)

[PE1-8] Allergen avoidance clinical trial: correlation of symptom scores between 4 and 6 point scoring systems

Todor A Popov1, Grigoriy Garyuk2, Igor Kaydashev3, Svitlana Kharkivska4, Yasuo Ohashi5, Kimihiro Okubo6 (1.Department of Occupational Disease, University Hospital Sv. Ivan Rilskipational, Bulgaria, 2.Private Enterprise “Garyuk”, Ukraine, 3.1st City Clinical Hospital of Poltava City Council, Ukraine, 4.Medical Center “Family Health”, Ukraine, 5.Department of Integrated Science and Engineering for Sustainable Society, Chuo University, Japan, 6.Department of Otorhinolaryngology, Nippon Medical School, Japan)

[PE1-11] Evaluation of mucus plugs and bronchial wall thickening on three-dimensional computed tomography in patients with unexplained chronic cough whose sputum yielded filamentous basidiomycetes

Haruhiko Ogawa1, Kenichiro Okumura2, Yuichi Yoshie2, Takahiro Nadamura3, Kazuya Tone4, Noriyuki Ohkura5 (1.Department of Environmental and Preventive Medicine, Kanazawa University, Japan, 2.Department of radiology, Kanazawa University Graduate School of Medical Sciences, Japan, 3.Radiology Department, Ishikawa-ken Saiseikai Kanazawa Hospital, Japan, 4.Division of Respiratory Medicine, Jikei University School of Medicine, Japan, 5.Respiratory Medicine, Kanazawa University Hospital, Japan)

[PE1-13] The disease burden and quality of life of chronic cough patients in Japan

Takekazu Kubo1, Keisuke Tobe2, Kotoba Okuyama1, Masashi Kikuchi3, Chen Yirong5, Schelfhout Jonathan4, Machiko Abe2, Shigeru Tokita1 (1.Medical Affairs, MSD K.K., Japan, 2.Market Access, MSD K.K., Japan, 3.Clinical Research, Japan Development, MSD K.K., Japan, 4.Outcomes Research, Merck & Co., Inc., United States of America, 5.Health Division, Kantar, Singapore)

[PE1-15] dsRNA and staphylococcal enterotoxin B induces opposite inflammatory reactivity in epithelial cell

Jun-Pyo Choi1, Kyung-Min Ahn2, Purevsuren Losol1,3, Yong Hyun Kim1,2, Sae-Hoon Kim1,2,3, Sang-Heon Cho2, Yoon-Seok Chang1,2,3 (1.Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea, 2.Department of Internal Medicine, Seoul National University College of Medicine, Republic of Korea, 3.Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Council, Republic of Korea)

[PE1-16] THP-1 derived macrophage shows different responses to polyI:C and staphylococcal enterotoxin

Jun-Pyo Choi1, Purevsuren Losol1,2, Yong Hyun Kim1,3, Sae-Hoon Kim1,2,3, Sang-Heon Cho2,3, Yoon-Seok Chang1,2,3 (1.Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Republic of Korea, 2.Institute of Allergy and Clinical Immunology, Seoul National University Medical Research Council, Republic of Korea, 3.Department of Internal Medicine, Seoul National University College of Medicine, Republic of Korea)

[PE1-18] Investigation of the number of oral bacteria and the conditions of asthma, COPD, and ACO

Toshiya Inui1, Yukiko Abe1, Tatsuya Shirai1, Kouzo Suhara1, Maya Tsuchiya1, Takayasu Watanabe1, Mitsuru Sada1, Atsuto Mouri1, Shinkichi Iwanari2, Mitsuhiro Kamimura1 (1.Pulmonology Department, National Hospital Organization Disaster Medical Center, Japan, 2.Department of Oral and Maxillofacial Surgery, National Hospital Organization Disaster Medical Center, Japan)